Press release
Wet AMD Market Size in the 7MM was ~USD 7,783 million in 2023 and is expected to increase by 2034, estimates DelveInsight
Unlock key insights into the Wet AMD Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Wet AMD Market Size [https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Wet AMD Market Report
* In June 2025, Amgen announced a study is to compare the efficacy and safety of ABP 938 versus Aflibercept (Eylea Registered ) in the treatment of neovascular age-related macular degeneration. Subjects will be randomized in a masked 1:1 ratio to receive 2 mg (0.05 mL) of either ABP 938 (Treatment Group A) or aflibercept (Treatment Group B) administered by intravitreal (IVT) injection.
* In June 2025, Adverum Biotechnologies Inc. conducted a Phase 3 study in a broad participant population (treatment-naive and treatment-experienced) with neovascular (wet) age-related macular degeneration (nAMD). The study will evaluate a single intravitreal (IVT) injection of Ixo-vec compared to an active comparator. The primary endpoint of this study is the mean change in best corrected visual acuity (BCVA) of Ixo-vec compared to an active comparator measured at an average of Weeks 52 and 56.
* In June 2025, Kodiak Sciences Inc. organized a Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tarcocimab Tedromer and Tabirafusp Tedromer Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration.
* In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of Age-Related Macular Degeneration (AMD) in the 7MM were nearly 40 million in 2023.
* The highest total diagnosed prevalent cases of Age-Related Macular Degeneration (AMD) were accounted by the US in 2023 (~14 million), which are expected to show a rise in the future.
* Among the European countries, Germany had the highest diagnosed prevalent cases of Age-Related Macular Degeneration (AMD) with ~6 million cases in 2023. On the other hand, Spain had the lowest prevalent population (~2 million cases).
* Japan had nearly 8 million total diagnosed prevalent cases of Age-Related Macular Degeneration (AMD) in 2023, accounting for approximately 21% in 7MM.
* Based on age-specific segmentation, the people in the age group of 70-79 were affected the most by Wet Age-Related Macular Degeneration (Wet AMD) in the US, accounting for approximately 406 thousand cases in 2023.
* The DelveInsight analysis indicates that in Japan, there are more number of cases of people with Dry AMD than people with Wet AMD, with approximately 90% of total cases and 10% of cases in 2023.
* Among the European countries, Germany had the highest diagnosed prevalent cases of Wet AMD with ~595 thousand cases, followed by France, which had prevalent population of ~389 thousand in 2023. On the other hand, Spain had the lowest prevalent population (~160 thousand cases).
* Japan had ~840 thousand total diagnosed prevalent cases of Wet Age-Related Macular Degeneration (Wet AMD) in 2023, accounting for approximately 21% in 7MM.
* In 2023, in the US, the age-specific diagnosed prevalent cases of Wet AMD were highest for age group 70-79 (~407 thousand), followed by 60-69 (~393 thousand), =80 (~304 thousand), and 50-59 (~252 thousand).
* The leading Wet AMD Companies such as Opthea Limited, Outlook Therapeutics, Kodiak Sciences, Regenxbio, Dobecure, Gemini Therapeutics, Huabo Biopharm, Isarna Therapeutics, IVERIC bio (formerly Ophthotech Corporation), Ribomic, Curacle, Bio-Thera Solutions, AngioLab Inc, Alkahest, Tyrogenex, Iconic Therapeutics, AiViva BioPharma, Boehringer Ingelheim, RemeGen, and others.
* Promising Wet AMD Pipeline Therapies such as NT-101 0.05 mM, Eylea Registered (Aflibercept), Intravitreal aflibercept injection, RGX-314, ABP 938, Aflibercept, Ixo-vec, Ranibizumab , and others.
Stay ahead in the competitive landscape of the Wet AMD Market. Access DelveInsight's in-depth market analysis and strategic insights today! Click here for more @ Wet AMD Treatment Market Size [https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Wet AMD Epidemiology Segmentation in the 7MM
* Total Wet AMD Prevalent Cases
* Wet AMD Diagnosed Prevalent Cases
* Wet AMD Type-Specific Diagnosed Prevalent Cases
* Total Wet AMD Age-Specific Cases
Download the report to understand which factors are driving Wet AMD Epidemiology trends @ Wet AMD Prevalence [https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Wet Age-Related Macular Degeneration Marketed Drugs
* BEOVU (Brolucizumab): Novartis
BEOVU (Brolucizumab), developed by Novartis, is a potent anti-VEGF treatment used for Wet Age-Related Macular Degeneration (Wet-AMD). It works by inhibiting vascular endothelial growth factor, reducing abnormal blood vessel growth and fluid leakage in the retina. BEOVU offers a longer dosing interval, allowing up to 12-week dosing schedules.
* EYLEA (aflibercept): Regeneron Pharmaceuticals
EYLEA, developed by Regeneron, is used to treat wet age-related macular degeneration (wet-AMD), diabetic eye disease, and other retinal issues. The drug, aflibercept, is an injectable treatment that slows vision loss by blocking abnormal blood vessel growth in the eye. EYLEA works as a soluble decoy receptor, inhibiting VEGF-A and PlGF to prevent abnormal blood vessel formation. The standard dosage is 2 mg every 4 weeks for the first 3 months, then every 8 weeks. Regeneron is currently testing less frequent dosing and higher doses in ongoing phase III trials.
* VABYSMO (faricimab): Roche/ Genentech, Inc.
VABYSMO (faricimab) is the first bispecific antibody designed for the eye. It targets and inhibits two signalling pathways linked to a number of vision-threatening retinal conditions by neutralizing angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Ang-2 and VEGF-A contribute to vision loss by destabilizing blood vessels, causing new leaky blood vessels to form and increasing inflammation. By blocking both pathways involving Ang-2 and VEGF-A, VABYSMO is designed to stabilize blood vessels.
Wet Age-Related Macular Degeneration Emerging Drugs
* OPT-302: Opthea Limited
OPT-302 (sVEGFR-3) is the first 'Trap' inhibitor of VEGF-C and VEGF-D designed specifically for the eye. OPT-302 blocks the two members of the VEGF family which cause blood vessels to grow and leak. Aberrant blood vessel growth and vascular leakage are hallmarks of several eye diseases, including wet AMD and DME. In combination with anti-VEGF-A therapies, OPT-302 completely shuts-down VEGFR-2 and VEGFR-3 activity and targets mechanisms of resistance and suboptimal clinical response to existing therapies.
* KSI-501: Kodiak Sciences Inc.
KSI-501 is a novel anti-VEGF biologic designed to rapidly inhibit VEGF and provide extended durability of action to reduce the burden of frequent anti-VEGF injections. Delivering potent and sustained VEGF inhibition enables patient compliance, results in long-term efficacy, and improves visual acuity outcomes.
Discover the future of Wet AMD Treatments with DelveInsight's latest market report. Get expert insights and forecasts-download now! @ Wet AMD Market Drivers and Barriers [https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Wet AMD Companies
Opthea Limited, Outlook Therapeutics, Kodiak Sciences, Regenxbio, Dobecure, Gemini Therapeutics, Huabo Biopharm, Isarna Therapeutics, IVERIC bio (formerly Ophthotech Corporation), Ribomic, Curacle, Bio-Thera Solutions, AngioLab Inc, Alkahest, Tyrogenex, Iconic Therapeutics, AiViva BioPharma, Boehringer Ingelheim, RemeGen, and others.
Scope of the Wet AMD Market Report
* Coverage- 7MM
* Study Period- 2020- 2034
* Wet AMD Companies- Opthea Limited, Outlook Therapeutics, Kodiak Sciences, Regenxbio, Dobecure, Gemini Therapeutics, Huabo Biopharm, Isarna Therapeutics, IVERIC bio (formerly Ophthotech Corporation), Ribomic, Curacle, Bio-Thera Solutions, AngioLab Inc, Alkahest, Tyrogenex, Iconic Therapeutics, AiViva BioPharma, Boehringer Ingelheim, RemeGen, and others.
* Wet AMD Pipeline Therapies- NT-101 0.05 mM, Eylea Registered (Aflibercept), Intravitreal aflibercept injection, RGX-314, ABP 938, Aflibercept, Ixo-vec, Ranibizumab , and others.
* Wet AMD Therapeutic Assessment: Wet AMD Current Marketed and Wet AMD Emerging Therapies
* Wet AMD Market Dynamics: Wet AMD market drivers and Wet AMD market barriers
* Wet AMD Unmet Needs, KOL's views, Analyst's views, Wet AMD Market Access and Reimbursement
Explore the dynamics of the Wet AMD Market with DelveInsight. From market size to emerging drugs-find it all in our latest report. Read now! @ Wet AMD Ongoing Clinical Trials Analysis [https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
1 Key Insights
2 Wet AMD Market Report Introduction
3 Wet AMD Market Overview at a Glance
4 Wet AMD Market: Future Perspective
5 Executive Summary
6 Key Events
7 Wet AMD Market Disease Background and Overview
8 Wet AMD Epidemiology and Patient Population
9 Patient Journey
10 Wet AMD Marketed Drugs
11 Wet AMD Emerging Drugs
12 Wet AMD: Market Analysis
13 Key Opinion Leaders' Views
14 Wet AMD SWOT Analysis
15 Wet AMD Unmet Needs
16 Wet AMD Market Access and Reimbursement
17 Appendix
18 DelveInsight Capabilities
19 Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=wet-amd-market-size-in-the-7mm-was-usd-7783-million-in-2023-and-is-expected-to-increase-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wet AMD Market Size in the 7MM was ~USD 7,783 million in 2023 and is expected to increase by 2034, estimates DelveInsight here
News-ID: 4080428 • Views: …
More Releases from ABNewswire
Trusted Legal Defense from Experienced Criminal Attorneys in Richmond and Nearby …
When legal trouble arises, the importance of securing the right legal representation cannot be overstated. Brooks & Baez offers professional advocacy for individuals facing criminal charges, ensuring each case is met with strategic defense. The role of a criminal defense lawyer is to provide critical support and guidance through some of the most challenging situations a person can encounter. A skilled criminal defense lawyer reviews the facts, investigates every angle,…
Eosinophilic Esophagitis Treatment Market Size in the 7MM was ~USD 1,800 million …
DelveInsight's "Eosinophilic Esophagitis Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Eosinophilic Esophagitis historical and forecasted epidemiology as well as the Eosinophilic Esophagitis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Unlock key insights into the Eosinophilic Esophagitis Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Eosinophilic…
Thymidine Kinase 2 Deficiency Market Size in the 7MM was ~USD 1 million in 2023 …
DelveInsight's "Thymidine Kinase 2 Deficiency Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Thymidine Kinase 2 Deficiency epidemiology, market, and clinical development understanding, Addition to this report provides historical and forecasted epidemiology and market data as well as a detailed analysis on the Thymidine Kinase 2 Deficiency therapeutics market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom,…
Kidney Transplant Rejection Therapeutics Market Size in 7MM is expected to grow …
DelveInsight's "Kidney Transplant Rejection Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of kidney transplant rejection, historical and forecasted epidemiology, as well as the kidney transplant rejection therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Unlock key insights into the Kidney Transplant Rejection Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and…
More Releases for Wet
Global Wet Cat Food Market and Trends
According to a new report published by Allied Market Research, titled, "Wet Cat Food Market by Product Type, End User, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030," The lockdown across various countries and ban on international travel has disrupted the supply chain and revenue chain.
The global wet cat food market size was valued at $4.6 billion in 2020, and is projected to reach $7.9 billion by 2030,…
Oscillation Flowmeters for Dry and Wet Gases
Oscillation is a measurement method that is unique for gases and can be used in a variety of ways for flow measurement with the aid of a flow oscillator. With this unique measuring method, a partial flow of the medium is passed through a bypass into the oscillator. In the oscillator, the medium flows through a chamber with two flow channels. A bluff body deflects the flow either in one…
Emirates Wet Wipes Partners with Medialinks
Emirates Wet Wipes, one of the largest hygiene care products manufacturers in the GCC, is ramping up its advertising and brand direction with the appointment of integrated digital & ecommerce agency, Medialinks, to its pan-Arab business.
Medialinks will be EWW’s first retained agency to oversee company’s entire digital account, which will encompass a fully optimized website, advertising, social, search engine optimisation and analytics.
The appointment happened after three-month competitive pitch process.…
Cross Fold Wet Tissue Market|| Worldwide, 2030
The “Cross Fold Wet Tissue Market Analysis to 2030” is a specialized and in-depth study of the Cross Fold Wet Tissue industry with a focus on the Cross Fold Wet Tissue market trend. The report aims to provide an overview of the Cross Fold Wet Tissue market with detailed market segmentation by component, application, end-user, and geography. The Cross Fold Wet Tissue market is expected to witness high growth during…
Global Cat Wet Food Market 2017 - NORY, WIK, Wanpy, Nature Bridge, WET NOSES
Apex Research, recently published a detailed market research study focused on the "Cat Wet Food Market" across the global, regional and country level. The report provides 360° analysis of "Cat Wet Food Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cat Wet Food industry, and estimates the future trend of Cat…
Emerging Opportunities in Wet Macular Degeneration Market
Wet Macular Degeneration Market: Overview
Macular degeneration is a weakening or collapsed working of the eyes’ macula. Macula is the small area on the retinal surface covered by the light-sensitive tissue lining which is blackish area of the eye. This part of the retina is responsible for individual’s central vision, allows viewing fine objects clearly. Generally old aged people develop macular degeneration because of natural aging process of the body. There…
